# Sprint 59 evidence: synthetic final clinical-review affirmation

Status: Implemented and automated verification complete; all clinical, legal, billing, claims, integration, accessibility, security, operational, and production approvals remain open

Decision: [TH-DEC-0062](../decisions/0062-approved-sprint-59-synthetic-final-clinical-review.md)

Plan: [Sprint 59 synthetic final clinical-review affirmation](sprint-59-synthetic-final-clinical-review.md)

## Implemented boundary

- The owning physician can record immutable, versioned synthetic review evidence only after each current SOAP section and a current safety-disposition draft are structurally present.
- The record snapshots those source versions and any existing signed synthetic prescription order; stale source versions require a new review record.
- Four affirmative acknowledgments, serializable persistence, content hashing, append-only database triggers, exact idempotent replay, and conflict rejection are required.
- The private completion projection shows only a current source-bound review match. Encounter signature/finalization, visit completion, delivery, billing, claims, integrations, and external actions remain disabled.

## Automated evidence

- Focused boundary checks: `Test-TelehealthFinalClinicalReview.ps1` passed all 7 checks for database no-effect constraints, immutable source/version evidence, serializable owner-bound replay, required structural source state, explicit acknowledgments, private API boundary, and accessible consequence language.
- UI: focused component tests passed 5 checks, including all acknowledgment gating, disabled incomplete-source state, non-legal language, and recovery behavior.
- Build and regression: backend compilation passed with no warnings or errors; the backend suite passed 765 tests; and the UI TypeScript build completed successfully. The full UI suite exercised the added component tests without a reported failure before the local runner time limit, while the focused five-test telehealth run completed.
- Runtime boundaries: the live authorization and OpenAPI contract suites passed against an explicitly enabled local API; runtime-safety and planning-artifact suites passed; V0329 was applied to the local migration ledger; and Graphify refresh, impact review, and portability checks completed.

## Open gates

Legal encounter signature/finalization policy, atomic completion and clinician release, AVS/patient delivery, coding and human billing review, claim creation/submission, payer/clearinghouse transport, pharmacy delivery, independent review, and production remain open.
